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We present three cases of trisomy 9 mosaicism diagnosed by amniocentesis with ongoing pregnancies after referral to our center
due to fetal abnormalities. Two cases were associated with severe fetal growth restriction (FGR), each of which resulted in an
intrauterine fetal demise (IUFD) in the third trimester. The other case involved mild FGR with a congenital diaphragmatic hernia
and resulted in a live birth with severe development delay. A major prenatal ﬁnding of trisomy 9 mosaicism is FGR. Fetuses with
trisomy 9 mosaicism can rarely survive in the case of severe FGR.
1.Introduction
Trisomy9mosaicismisararechromosomalabnormalitythat
manifests with multiple anomalies, such as facial, cardiac,
osteal, genitourinary, and respiratory abnormalities. More
than 50 cases have been reported, most of which were
diagnosed after birth. As cases diagnosed prenatally usually
culminate in induced abortions [1–4], the natural history
of fetuses with trisomy 9 mosaicism remains unknown. We
report three cases of trisomy 9 mosaicism diagnosed in utero
with ongoing pregnancies.
2.CaseReport
A 36-year-old primigravida was referred to our institute at
29 weeks of gestation because of fetal growth restriction
(FGR). A fetal ultrasound examination demonstrated severe
asymmetric FGR (<−3.0 standard deviation [SD]) and a
single umbilical artery (SUA). An amniocentesis revealed
that 27 were normal 46, XX cells and 3 cells (10%) were 47,
XX, +9. An intrauterine fetal demise (IUFD) was conﬁrmed
at 33 weeks of gestation. The fetus was a 915g female with
a large forehead, a bulbous nose, and micrognathia. The
placental weight was 150g. An autopsy revealed an abnormal
lobulation of the right lung.
The second case was that of a 36-year-old primigravida.
She was referred to our institute at 31 weeks of gestation
due to a left-sided congenital diaphragmatic hernia. The
estimated fetal body weight by ultrasound was 1408g (−1.7
SD). The fetal karyotype by amniocentesis indicated trisomy
9 mosaicism with 29% (6/21 cells) trisomic cells. At 37 weeks
of gestation, a 1506g male was delivered by elective cesarean
section. The placenta weighed 350g. The diaphragmatic
hernia was repaired on day 2 of life, followed by a gastros-
tomy and bronchotomy in the 1st year. Although he had
normal G-banding results on postnatal blood karyotyping,
interphase FISH performed on abdominal wall muscle tissue
obtained during the gastrostomy revealed a mosaic trisomy
9 karyotype. This case has been reported to highlight the
cytogenetic discrepancy between amniocytes and postnatal
blood [5]. He is now 4 years old and suﬀers from severe
developmental delay.
The third case involved a 41-year-old primigravida. She
was referred for evaluation of FGR at 26 weeks of gestation.
An ultrasound examination revealed severe asymmetric
FGR 530g (−3.2 SD) and an SUA. Chromosomes from2 Obstetrics and Gynecology International
Table 1: Clinical ﬁndings of trisomy 9 mosaicism with high
frequency.
Prenatally
Fetal growth restriction
Ventricular septal defect
Micrognathia
Single umbilical artery
Amniotic ﬂuid disorders
Postnatally
Craniofacial abnormalities
Wide fontanels
Microphthalmia
Bulbous nose
Low-set ears
Micrognathia
Heart abnormalities
Ventricular septal defect
Patent ductus arteriosus
Genitourinary malformations
Hydronephrosis
Microkidneys
Musculoskeletal abnormalities
Dislocated hips
Joint limitation
Overlapping ﬁngers
Abnormal ossiﬁcation
amniocentesis revealed a mosaic trisomy 9 constitution, as
follows: 46, XX (18 cells)/47, XX, +9 (11 cells). An IUFD was
conﬁrmed at 38 weeks of gestation. The fetus was a 1220g
female. The placenta weighed 107g. An autopsy revealed
no major abnormalities except facial dysmorphism with a
bulbous nose, micrognathia, and low-set ears.
3. Discussion
We have reported three cases of trisomy 9 mosaicism
diagnosed by amniocentesis with ongoing pregnancies. FGR
was observed prenatally, and speciﬁc facial ﬁndings were
observed after birth in all the cases. Two of three cases,
which showed severe FGR and SUA, resulted in IUFDs in the
third trimester. The other case with mild FGR resulted in a
live birth and had severe developmental delay. Fetuses with
trisomy 9 mosaicism in which the major prenatal ﬁnding
is FGR rarely survive, even though they have no major
anomalies.
Trisomy 9 mosaicism manifests with various abnormali-
ties.Facialanomalies,suchaslow-setears,micrognathia,and
bulbous nose, are universal. Cleft lip is expressed in about
20% of cases [6]. Orthopaedic abnormalities, including hip
dislocations and arthrogryposis, are also highly expressed.
Wide-ranging malformations, such as congenital heart dis-
ease, intracerebral lesions, and urogenital abnormalities, are
alsoobserved(Table1).Ourthreecaseshadcommonspeciﬁc
facial ﬁndings, such as micrognathia and bulbous noses.
Other malformations included a congenital diaphragmatic
hernia and an abnormal lobulation of the lung; these visceral
abnormalities are rare.
Postpartum cytogenetic conformation of trisomy 9
mosaicism was performed in only one case. If mosaicism is
detected in any one tissue, it is expected that diﬀerent tissues
will have diﬀerent levels of mosaicism and consequently the
clinical presentation of each case may vary considerably.
The case which underwent cytogenetic analysis postnatally
revealed cytogenetic discrepancies between the tissues [5].
There was a normal karyotype in the blood and trisomy 9
mosaicism in the abdominal wall tissue. In this case, the
infant demonstrated mild FGR with a congenital diaphrag-
matic hernia. When a cytogenetic discrepancy between
amniocytes and postnatal blood is observed, it is not rare
f o rm o s a i ct i s s u et ob ec o n ﬁ n e dt oas p e c i ﬁ co r g a n[ 5, 7].
We failed to perform postnatal cytogenetic analysis on the
other two cases which resulted in IUFDs. It is diﬃcult to
obtainusualG-bandingkaryotyperesultsonspecimensfrom
stillborn infants. However, these two cases were coincident
with a phenotype of trisomy 9 mosaicism, such as a
speciﬁc facial appearance, and the two stillborn infants were
considered to have trisomy 9 mosaicism.
Our search revealed 20 reported prenatal cases of trisomy
9mosaicism[3,8–12].Ofthe20cases,11resultedininduced
abortions, and the pregnancies were not interrupted in the
remaining 9 cases (Table 2). Of these 9 cases, 8 led to live
births and 1 case resulted in an IUFD [12]. In contrast,
two of three cases resulted in IUFDs in this report. In
general, many fetuses with common trisomies are lost before
birth. In terms of trisomy 21, which is the most common
aneuploidy, the estimated fetal death rate is 30% between the
2nd trimester and term [13]. Chromosomal abnormalities
were present in 38% of anomalous stillborns, and 4.6% of
morphologically normal fetuses of 750 stillbirths [14]. It is
not surprising, therefore, that two of three cases of trisomy
9 mosaicism resulted in IUFDs. The main feature of trisomy
9 mosaicism IUFDs is severe growth restriction. Two of the
three cases we evaluated had severe FGR without major
congenital abnormalities and resulted in IUFDs. According
to reported 12 cases including our own cases (Table 2), three
cases that resulted in IUFDs involved severe FGR. Adversely,
the other 9 cases of liveborn did not reveal severe FGR.
Arnold reviewed 23 cases of trisomy 9 mosaicism; most
were diagnosed postnatally with an average birth weight of
2690g, which is consistent with mild FGR [6]. In addition,
reported cases incidentally detected by midtrimester routine
amniocentesis associated with maternal advanced age led
to live births uneventfully (Table 2). Trisomy 9 mosaicism
can result in IUFDs when there is severe FGR, even though
there are no structural abnormalities. However, it is still
unknown whether the degree of FGR correlates with IUFDs
in chromosomal abnormalities.
Our cases contribute to clarifying the natural history
of trisomy 9 mosaicism diagnosed in utero. Trisomy 9
mosaicism fetuses with severe FGR can rarely survive. These
ﬁndings are helpful for genetic counseling for trisomy 9
mosaicism diagnosed.Obstetrics and Gynecology International 3
Table 2: Characteristics and outcomes of reported cases of prenatal trisomy 9 mosaicism.
Case Reference Maternal
age (years)
Time of exam
(weeks)
Trigger of
detection FGR Other fetal
ﬁndings Outcomes
1 Bureau et al. [8] 24 36 CNS anomaly − Dandy-Walker
variant
Liveborn, death at 2
weeks
2 Saura et al. [3]2 8 3 0 PDA,
polyhydramnios
− PDA Liveborn at 35 weeks
3 29 33 FGR + —
Alive at 21 months;
severe developmental
delay
4 Greenberg et al.
[9] 39 16 AAMA − —L i v e b o r n a t t e r m
5 Hsu et al. [10] 48 NA AAMA − — Normal development
at 3 years, 8 months
6 42 NA AAMA − — Liveborn at 23 weeks;
death at 4 days
7 38 NA AAMA + Multiple anomalies
(no details) Liveborn at term
8 Sherer et al. [11]2 0 3 1 F G R M i l d Right
hydronephrosis
liveborn, death at 6
weeks
9 Smoleniec et al.
[12] 28 34 Severe FGR Severe — IUFD at 34 weeks
10 Case 1 35 29 Severe FGR Severe — IUFD at 33 weeks
11 Case 2 in [5]3 6 3 1 C D H M i l d
Left-sided
congenital
diaphragmatic
hernia
Alive at 4 years; severe
developmental delay
12 Case 3 41 24 Severe FGR Severe — IUFD at 38 weeks
AAMA: amniocentesis with advanced maternal age; CNS: central nerve system; FGR: fetal growth restriction; IUFD: intrauterine fetal demise; PDA: patent
ductus arteriosus; NA: not available.
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